Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy

That is the title of a paper published today in Current Medical Research and Opinion with co-authors Nadine Zawadzki, Moises Marin, Ivana Audhya, Lauren Sedita, Natasha Kulkarni and Alexa Klimchak. The abstract is below. ObjectivesQuantify caregiver risk preferences to inform the “value of hope” for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of…

Read More

What is HEMA?

The Pink Sheet reports on a new international health technology assessment (HTA) body: Health Economics Methods Advisory group (HEMA). The Health Economics Methods Advisory group (HEMA) is a new, independent group of health technology assessment agencies from the US, England and Canada that will work together to develop recommendations on adopting novel health economic methods…

Read More